2018
DOI: 10.1093/abm/kay005
|View full text |Cite
|
Sign up to set email alerts
|

A Web-Delivered Multicomponent Intervention for Adolescents with Poorly Controlled Type 1 Diabetes: A Pilot Randomized Controlled Trial

Abstract: Background Type 1 diabetes is associated with significant mortality and economic cost. Management of type 1 diabetes involves completing multiple daily adherence behaviors, and many adolescents struggle with self-management and show poor glycemic control. Purpose The purpose was to conduct an unblinded pilot randomized controlled parallel-group study of a web-delivered multi-component intervention targeting self-monitoring of blood glucose, working memory, and parent supervision of diabetes care among adoles… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
46
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 31 publications
(59 citation statements)
references
References 44 publications
(61 reference statements)
1
46
0
Order By: Relevance
“…Sixty-one participants and their parents completed the study's intake assessment. There were not significant differences in clinical indicators (e.g., HbA1c and type of insurance) between those who participated and declined to participate (see Stanger et al, 2018). This sample size was selected for 80% power to detect a mean difference of 1.5 average daily glucose checks at 6-month follow-up, the primary outcome of the trial.…”
Section: Participantsmentioning
confidence: 99%
See 2 more Smart Citations
“…Sixty-one participants and their parents completed the study's intake assessment. There were not significant differences in clinical indicators (e.g., HbA1c and type of insurance) between those who participated and declined to participate (see Stanger et al, 2018). This sample size was selected for 80% power to detect a mean difference of 1.5 average daily glucose checks at 6-month follow-up, the primary outcome of the trial.…”
Section: Participantsmentioning
confidence: 99%
“…self-regulation, the ability to modulate cognitions, emotions, and behaviors toward long-term goals, is a key individual difference that has been associated with adherence behaviors, including SMBG, and glycemic control (Lansing, Crochiere, Cueto, Wiebe, & Berg, 2017;McNally, Rohan, Pendley, Delamater, & Drotar, 2010;Perez et al, 2016). A multicomponent, web-delivered intervention designed to target biopsychosocial processes in the self-regulation of SMBG in adolescents with above-target glycemic control was developed and tested, showing improvements in SMBG and HbA1c at 6-and 12-month follow-ups (Stanger, Lansing, Scherer, Budney, Christiano, & Casella, 2018). To target psychological, biological, and social processes associated with self-regulation for chronic illness self-management (Lansing & Berg, 2014), this intervention combined incentives for SMBG and brief web counseling (psychological) with working memory training (biological) for adolescents as well as parental contingency contracting training (focused on adolescent SMBG; social).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…This is reinforced by the perspectives of adolescents in pilot FI programs stating that extrinsic financial rewards aided them in realizing the intrinsic value of self‐care . While some trial programs incorporating FI have led to sustained improvements in participant HbA1c, others had non‐significant effects on glycemic control . This heterogeneity highlights the need for future work to optimize the structure of FI to appeal to adolescent preferences and address the multifactorial nature of glycemic control.…”
Section: Discussionmentioning
confidence: 99%
“…FI programs for adolescents with T1D led to improvements in the frequency of incentivized self‐care behaviors . Further, in some studies, but not all, increased engagement in self‐care persisted after the discontinuation of incentives and was associated with durable reductions in HbA1c . This suggests that FI not only has the potential to improve clinical outcomes but may lead to long‐term cost savings due to the relatively low cost of incentives as well as the preventative value of improved glycemic control.…”
Section: Introductionmentioning
confidence: 97%